3549 Stock Overview
Engages in the retail of pharmaceuticals, cosmetics, and daily goods in Japan.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 1/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 3549 from our risk checks.
Kusuri No Aoki Holdings Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥3,121.00 |
52 Week High | JP¥3,627.00 |
52 Week Low | JP¥2,670.33 |
Beta | -0.35 |
11 Month Change | 3.45% |
3 Month Change | 8.01% |
1 Year Change | 15.12% |
33 Year Change | 27.39% |
5 Year Change | 26.53% |
Change since IPO | 87.82% |
Recent News & Updates
Recent updates
Shareholder Returns
3549 | JP Consumer Retailing | JP Market | |
---|---|---|---|
7D | 3.3% | 3.2% | 0.1% |
1Y | 15.1% | 2.5% | 18.9% |
Return vs Industry: 3549 exceeded the JP Consumer Retailing industry which returned 2.5% over the past year.
Return vs Market: 3549 underperformed the JP Market which returned 18.9% over the past year.
Price Volatility
3549 volatility | |
---|---|
3549 Average Weekly Movement | 3.8% |
Consumer Retailing Industry Average Movement | 3.1% |
Market Average Movement | 3.8% |
10% most volatile stocks in JP Market | 7.3% |
10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 3549 has not had significant price volatility in the past 3 months.
Volatility Over Time: 3549's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | 4,460 | Hironori Aoki | www.kusuri-aoki-hd.co.jp |
Kusuri No Aoki Holdings Co., Ltd. engages in the retail of pharmaceuticals, cosmetics, and daily goods in Japan. The company offers vitamin and diet supplements; and first aid and health care supplies.
Kusuri No Aoki Holdings Co., Ltd. Fundamentals Summary
3549 fundamental statistics | |
---|---|
Market cap | JP¥295.23b |
Earnings (TTM) | JP¥12.31b |
Revenue (TTM) | JP¥436.88b |
24.0x
P/E Ratio0.7x
P/S RatioIs 3549 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
3549 income statement (TTM) | |
---|---|
Revenue | JP¥436.88b |
Cost of Revenue | JP¥318.78b |
Gross Profit | JP¥118.09b |
Other Expenses | JP¥105.78b |
Earnings | JP¥12.31b |
Last Reported Earnings
May 20, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 130.10 |
Gross Margin | 27.03% |
Net Profit Margin | 2.82% |
Debt/Equity Ratio | 76.7% |
How did 3549 perform over the long term?
See historical performance and comparison